Literature DB >> 25475166

Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury.

Jack Lawson1, Jonathan Elliott2, Caroline Wheeler-Jones2, Harriet Syme3, Rosanne Jepson3.   

Abstract

Chronic kidney disease (CKD) is a common medical condition of ageing cats. In most cases the underlying aetiology is unknown, but the most frequently reported pathological diagnosis is renal tubulointerstitial fibrosis. Renal fibrosis, characterised by extensive accumulation of extra-cellular matrix within the interstitium, is thought to be the final common pathway for all kidney diseases and is the pathological lesion best correlated with function in both humans and cats. As a convergent pathway, renal fibrosis provides an ideal target for the treatment of CKD and knowledge of the underlying fibrotic process is essential for the future development of novel therapies. There are many mediators and mechanisms of renal fibrosis reported in the literature, of which only a few have been investigated in the cat. This article reviews the process of renal fibrosis and discusses the most commonly cited mediators and mechanisms of progressive renal injury, with particular focus on the potential significance to feline CKD.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Ageing; CKD; Phosphate; Proteinuria; TGF-beta

Mesh:

Year:  2014        PMID: 25475166     DOI: 10.1016/j.tvjl.2014.10.009

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  26 in total

1.  Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats.

Authors:  Hong-Feng Zhang; Yan-Li Wang; Cheng Gao; Yan-Ting Gu; Jian Huang; Jin-Hui Wang; Jia-Hong Wang; Zhou Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-05-23       Impact factor: 6.150

2.  Assessment of Acute Kidney Injury and Renal Fibrosis after Renal Ischemia Protocols in Cats.

Authors:  Vanna M Dickerson; Daniel R Rissi; Cathy A Brown; Scott A Brown; Chad W Schmiedt
Journal:  Comp Med       Date:  2017-02-01       Impact factor: 0.982

Review 3.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

4.  [Screening active ingredients of Shenkangwan that regulate endothelial-mesenchymal transition of endothelial cells in vitro].

Authors:  Cha Zhang; Jia-Xing Zhang; Yi-Fan Xiong; Lu Lu; Ming-Qing Wang; Si-Ming Liu; Wei Xiao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-03-20

5.  Identification of CD2, CCL5 and CCR5 as potential therapeutic target genes for renal interstitial fibrosis.

Authors:  Chuanjie Zhang; Xin Hu; Feng Qi; Jun Luo; Xiao Li
Journal:  Ann Transl Med       Date:  2019-09

6.  A Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease.

Authors:  M Takenaka; A Iio; R Sato; T Sakamoto; H Kurumatani
Journal:  J Vet Intern Med       Date:  2017-11-13       Impact factor: 3.333

7.  Thymoquinone protects the rat kidneys against renal fibrosis.

Authors:  Rahimeh Bargi; Fereshteh Asgharzadeh; Farimah Beheshti; Mahmoud Hosseini; Mehdi Farzadnia; Majid Khazaei
Journal:  Res Pharm Sci       Date:  2017-12

8.  Clinical and histopathological features resembling those of human focal segmental glomerulosclerosis in a cat with nonimmune-mediated glomerulonephropathy.

Authors:  Go Sugahara; Satoshi Hosaka; Takayuki Mineshige; Junichi Kamiie; Kinji Shirota
Journal:  BMC Vet Res       Date:  2015-10-06       Impact factor: 2.741

9.  Cobrotoxin from Naja naja atra Venom Ameliorates Adriamycin Nephropathy in Rats.

Authors:  Shu-Zhi Wang; Yin-Li Xu; Qi Zhu; Jian-Qun Kou; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-11       Impact factor: 2.629

10.  Mineral analysis of complete dog and cat foods in the UK and compliance with European guidelines.

Authors:  M Davies; R Alborough; L Jones; C Davis; C Williams; D S Gardner
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.